Therefore, the present study revealed the upregulation and oncogenic roles of FBXO43, as well as the mechanism underlying the upregulation and oncogenic role of FBXO43, emphasizing the potential application of FBXO43/UBE2C/p53 axis in HCC targeted therapy. This evidence concerns the gene FBXO43 and hepatocellular carcinoma.